|
Report Date : |
13.03.2013 |
IDENTIFICATION DETAILS
|
Name : |
BAYER MATERIALSCIENCE LTD. |
|
|
|
|
Registered Office : |
43/F., Hopewell Center, 183 Queen’s Road East, Wanchai |
|
|
|
|
Country : |
Hong Kong |
|
|
|
|
Date of Incorporation : |
11.02.1998 |
|
|
|
|
Com. Reg. No.: |
21927744 |
|
|
|
|
Legal Form : |
Private Limited Company. |
|
|
|
|
Line of Business : |
Importer and Exporter of all kinds of plastic raw materials. |
|
|
|
|
No. of Employees : |
Company Employees: 180. (Hong Kong) - Including associates Group Employees:- (As at 30-06-2012) 112,300. (Whole Group) 14,800. (Bayer MaterialScience Subgroup) |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
Hong Kong |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
HONG KONG - ECONOMIC OVERVIEW
Hong Kong has a free market economy, highly dependent on international trade and finance - the value of goods and services trade, including the sizable share of re-exports, is about four times GDP. Hong Kong's open economy left it exposed to the global economic slowdown that began in 2008. Although increasing integration with China, through trade, tourism, and financial links, helped it to make an initial recovery more quickly than many observers anticipated, it again faces a possible slowdown as exports to the Euro zone and US slump. The Hong Kong government is promoting the Special Administrative Region (SAR) as the site for Chinese renminbi (RMB) internationalization. Hong Kong residents are allowed to establish RMB-denominated savings accounts; RMB-denominated corporate and Chinese government bonds have been issued in Hong Kong; and RMB trade settlement is allowed. The territory far exceeded the RMB conversion quota set by Beijing for trade settlements in 2010 due to the growth of earnings from exports to the mainland. RMB deposits grew to roughly 7.8% of total system deposits in Hong Kong by the end of 2011, an increase of over 59% since the beginning of the year. The government is pursuing efforts to introduce additional use of RMB in Hong Kong financial markets and is seeking to expand the RMB quota. The mainland has long been Hong Kong's largest trading partner, accounting for about half of Hong Kong's exports by value. Hong Kong's natural resources are limited, and food and raw materials must be imported. As a result of China's easing of travel restrictions, the number of mainland tourists to the territory has surged from 4.5 million in 2001 to 28 million in 2011, outnumbering visitors from all other countries combined. Hong Kong has also established itself as the premier stock market for Chinese firms seeking to list abroad. In 2011 mainland Chinese companies constituted about 43% of the firms listed on the Hong Kong Stock Exchange and accounted for about 56% of the Exchange's market capitalization. During the past decade, as Hong Kong's manufacturing industry moved to the mainland, its service industry has grown rapidly. Growth slowed to 5% in 2011. Credit expansion and tight housing supply conditions caused Hong Kong property prices to rise rapidly in 2010 and inflation to rise 5.3% in 2011. Lower and middle income segments of the population are increasingly unable to afford adequate housing. Hong Kong continues to link its currency closely to the US dollar, maintaining an arrangement established in 1983
|
Source
: CIA |
BAYER
MATERIALSCIENCE LTD.
43/F., Hopewell Center,
183 Queen’s Road East, Wanchai, Hong Kong.
PHONE: 2895 5888, 2158 2467
FAX: 3526 4505, 3526 4730
E-MAIL: dirk.lang@bayermaterialscience.com
Managing
Director: Mr. Johannes Matthias Dietsch
Incorporated on: 11th February, 1998.
Organization: Private Limited Company.
Capital: Nominal: HK$100,000.00
Issued: HK$100,000.00
Business Category: Plastic Material Trader.
Group Turnover: (Year ended 31-12-2011)
€36,528 million (Whole Group)
€10,832 million (Bayer MaterialScience Subgroup)
Company Employees: 180. (Hong Kong) - Including associates
Group Employees:- (As at 30-06-2012)
112,300. (Whole Group)
14,800. (Bayer MaterialScience Subgroup)
Main Dealing Banker: Deutsche Bank AG, Hong Kong Branch.
Banking Relation: Good.
Registered Head Office:-
43/F., Hopewell Center, 183 Queen’s Road East, Wanchai, Hong Kong.
Holding Company:-
Bayer Far East Service Co. Ltd., Hong Kong.
Intermediate Holding Company:-
Bayer MaterialScience AG, Germany.
Ultimate Holding Company:-
Bayer AG, Germany.
Associated/Affiliated Companies:-
Bayer Group of Companies
Alcafleu Management GmbH & Co. KG, Germany.
Alimtec S.A., Chile.
Athenix Corp., USA.
Baulé S.A.S., France.
Bayer (China) Ltd., China.
Bayer (Malaysia) Sdn. Bhd., Malaysia.
Bayer (Proprietary) Ltd., South Africa.
Bayer (Schweiz) AG, Switzerland.
Bayer (Sichuan) Animal Health Co. Ltd., China.
Bayer (South East Asia) Pte Ltd., Singapore.
Bayer 04 Immobilien GmbH, Germany.
Bayer 04 Leverkusen Fußball GmbH, Germany.
Bayer A/S, Denmark.
Bayer AB, Sweden.
Bayer AGCO Ltd., UK.
Bayer Agriculture Ltd., UK.
Bayer Altersversorgung GmbH, Germany.
Bayer Animal Health GmbH, Germany.
Bayer Antwerpen NV, Belgium.
Bayer AS, Norway.
Bayer Australia Ltd., Australia.
Bayer Austria Gesellschaft m.b.H., Austria.
Bayer B.V., Netherlands.
Bayer Beteiligungsverwaltung Goslar GmbH, Germany.
Bayer BioScience Pvt. Ltd., India.
Bayer Bitterfeld GmbH, Germany.
Bayer Boliviana Ltda., Bolivia.
Bayer Bulgaria EOOD, Bulgaria.
Bayer Business and Technology Services LLC, USA.
Bayer Business Services GmbH, Germany.
Bayer Business Services Private Ltd., India.
Bayer Canadian Holdings Inc., Canada.
Bayer Capital Corporation B.V., Netherlands.
Bayer Central America Sociedad Anonima, Costa Rica.
Bayer Chemicals AG, Germany.
Bayer Co. (Malaysia) Sdn. Bhd., Malaysia.
Bayer Consumer Care AG, Switzerland.
Bayer Corporation, USA.
Bayer Cotton Seed International Inc., USA.
Bayer CropScience (China) Co. Ltd., China.
Bayer CropScience (Portugal) Produtos para a Agricultura, Lda., Portugal.
Bayer CropScience (Private) Ltd., Pakistan.
Bayer CropScience AG, Germany.
Bayer CropScience Beteiligungsgesellschaft mbH, Germany.
Bayer CropScience Deutschland GmbH, Germany.
Bayer CropScience Holding Inc., USA.
Bayer CropScience Holding SA, France.
Bayer CropScience Holdings Inc., Canada.
Bayer CropScience Holdings Ltd., UK.
Bayer CropScience Holdings Pty Ltd., Australia.
Bayer CropScience Inc., Canada.
Bayer CropScience Inc., USA.
Bayer CropScience K.K., Japan.
Bayer CropScience LLC, USA.
Bayer CropScience LP, USA.
Bayer CropScience Ltd., Bangladesh.
Bayer CropScience Ltd., India.
Bayer CropScience Ltd., South Korea.
Bayer CropScience Ltd., UK.
Bayer CropScience N.V., Belgium.
Bayer CropScience Norwich Ltd., UK.
Bayer CropScience Pty Ltd., Australia.
Bayer CropScience Raps GmbH, Germany.
Bayer CropScience S.r.l., Italy.
Bayer CropScience Vermögensverwaltungsgesellschaft mbH, Germany.
Bayer CropScience, Inc., Philippines.
Bayer CropScience, S.L., Spain.
Bayer d.o.o., Croatia.
Bayer d.o.o., Serbia.
Bayer d.o.o., Slovenia.
Bayer de Mexico, S.A. de C.V., Mexico.
Bayer Direct Services GmbH, Germany.
Bayer East Africa Ltd., Kenya.
Bayer Far East Service Co. Ltd., Hong Kong.
Bayer Finance & Portfolio Management S.A., Chile.
Bayer Finance Ltda., Chile.
Bayer Gastronomie GmbH, Germany.
Bayer Gesellschaft für Beteiligungen mbH, Germany.
Bayer Global Investments B.V., Netherlands.
Bayer HealthCare AG, Germany.
Bayer HealthCare Co. Ltd., China.
Bayer HealthCare LLC, USA.
Bayer HealthCare Manufacturing S.r.l., Italy.
Bayer HealthCare Pharmaceuticals Inc., USA.
Bayer HealthCare Pharmaceuticals LLC, USA.
Bayer Hellas AG, Greece.
Bayer Hispania, S.L., Spain.
Bayer Holding Ltd., Japan.
Bayer Hungaria Kft., Hungary.
Bayer IMSA, S.A. de C.V., Mexico.
Bayer Inc., Canada.
Bayer Innovation GmbH, Germany.
Bayer International S.A., Switzerland.
Bayer International Trade Services Corporation, USA.
Bayer Israel Ltd., Israel.
Bayer Jinling Polyurethane Co. Ltd., China.
Bayer Korea Ltd., South Korea.
Bayer Ltd., Ireland.
Bayer Ltd., Ukraine.
Bayer MaterialScience (Beijing) Co. Ltd., China.
Bayer MaterialScience (China) Co. Ltd., China.
Bayer MaterialScience (Qingdao) Co. Ltd., China.
Bayer MaterialScience (Shanghai) Management Co. Ltd., China.
Bayer MaterialScience AG, Germany.
Bayer MaterialScience Customer Services GmbH, Germany.
Bayer MaterialScience GmbH, Germany.
Bayer MaterialScience LLC, USA.
Bayer MaterialScience Ltd., Japan.
Bayer MaterialScience Ltd., South Korea.
Bayer MaterialScience N.V., Belgium.
Bayer MaterialScience Oldenburg GmbH & Co. KG, Germany.
Bayer MaterialScience Private Ltd., India.
Bayer MaterialScience Pty Ltd., Australia.
Bayer MaterialScience S.p.A., Italy.
Bayer MaterialScience S.r.l., Italy.
Bayer MaterialScience, S.L., Spain.
Bayer Middle East FZE, UAE.
Bayer N.V., Belgium.
Bayer New Zealand Ltd., New Zealand.
Bayer Nordic SE, Finland.
Bayer Oy, Finland.
Bayer Pakistan (Private) Ltd., Pakistan.
Bayer Pearl Polyurethane Systems FZCO, UAE.
Bayer Pharma AG, Germany.
Bayer Pharma Chemicals Inc., USA.
Bayer Pharmaceuticals Private Ltd., India.
Bayer Philippines, Inc., Philippines.
Bayer Polyols S.N.C., France.
Bayer Polyurethanes B.V., Netherlands.
Bayer Polyurethanes Taiwan Ltd., Taiwan.
Bayer Portugal S.A., Portugal.
Bayer Public Ltd. Co., UK.
Bayer Puerto Rico Inc., Puerto Rico.
Bayer Real Estate GmbH, Germany.
Bayer S.A. de C.V., Honduras.
Bayer S.A., Argentina.
Bayer S.A., Brazil.
Bayer S.A., Chile.
Bayer S.A., Colombia.
Bayer S.A., Costa Rica.
Bayer S.A., Dominican Republic.
Bayer S.A., Ecuador.
Bayer S.A., Guatemala.
Bayer S.A., Morocco.
Bayer S.A., Nicaragua.
Bayer S.A., Panama.
Bayer S.A., Paraguay.
Bayer S.A., Peru.
Bayer S.A., Uruguay.
Bayer S.A., Venezuela.
Bayer S.A.S., France.
Bayer S.p.A., Italy.
Bayer s.r.o., Czech Republic.
Bayer Santé Familiale SAS, France.
Bayer Santé SAS, France.
Bayer Schering Pharma AG, Germany.
Bayer Sp. z.o.o., Poland.
Bayer Taiwan Co. Ltd., Taiwan.
Bayer Technology and Engineering (Shanghai) Co. Ltd., China.
Bayer Technology Services GmbH, Germany.
Bayer Thai Co. Ltd., Thailand.
Bayer TPU (Shenzhen) Co. Ltd., China.
Bayer Türk Kimya Sanayi Ltd. Sirketi, Turkey.
Bayer Uretech Ltd., Taiwan.
Bayer Verwaltungsgesellschaft für Anlagevermögen m.b.H., Germany.
Bayer Vietnam Ltd., Vietnam.
Bayer Vital GmbH, Germany.
Bayer Weimar GmbH & Co. AG, Germany.
Bayer Yakuhin Ltd., Japan.
Bayer Zydus Pharma Private Ltd., India.
Bayer, S.A., El Salvador.
Bayer, spol. s.r.o., Slovakia.
Bayer-Handelsgesellschaft mit beschränkter Haftung, Germany.
Baypo I LLC, USA.
Baypo II LLC, USA.
BAYPO Ltd. Partnership, USA.
BaySystems Pearl Ltd. Liability Co., UAE.
Berlimed, S.A., Spain.
Berlis AG, Swizerland.
Bilag Industries Private Ltd., India.
Biogenetic Technologies B.V., Netherlands.
BIPPO Corporation, USA.
Chemie-Beteiligungsaktiengesellschaft, Switerland.
Chemion Logistik GmbH, Germany.
Collateral Therapeutics Inc., USA.
Cooper Land Co. of New Jersey Inc., USA.
Corporación Bonima S.A. de C.V., El Salvador.
Currenta GmbH & Co. OHG, Germany.
DIC Bayer Polymer Ltd., Japan.
Drugofa GmbH, Germany.
Dynevo GmbH, Germany.
Epurex Films GmbH & Co. KG, Germany.
Erste K-W-A Beteiligungsgesellschaft mbH, Germany.
Euroservices Bayer GmbH, Germany.
Euroservices Bayer S.L., Spain.
Generics Holding GmbH, Germany.
Goiania Investimentos e Participacões Ltda, Brazil.
GP Grenzach Produktions GmbH, Germany.
Guangzhou Bayer MaterialScience Co. Ltd., China.
Guidance Interactive Healthcare Inc., USA.
Hild Samen GmbH, Germany.
Hornbeck Seed Co., Inc., USA.
Imaxeon Pty. Ltd., Australia.
Indurisk Rückversicherung AG, Luxembourg.
Intendis Austria Handels GesmbH, Austria.
Intendis GmbH, Germany.
Intendis Inc., USA.
Intendis llac Ticaret Ltd. Sirketi, Turkey.
Intendis Manufacturing S.p.A., Italy.
Intendis S.p.A., Italy.
Intraserv GmbH & Go. AG, Germany.
iSense Corporation, USA.
iSense Development Corporation, USA.
Jenapharm GmbH & Co. AG, Germany.
KOSINUS Grundstücks-Verwaltungsgesellschaft mbH & Co. Gamma OHG, Germany.
KVP Pharma+Veterinär Produkte GmbH, Germany.
Lyondell Bayer Manufacturing Maasvlakte VOF, Netherlands.
Marotrast GmbH, Germany.
Medipharm (Pvt) Ltd., Pakistan.
Mediterranean Seeds Ltd., Israel.
Mediwest Norway AS, Norway.
Medrad Asia Pte. Ltd., Singapore.
Medrad Belgium B.V., Belgium.
Medrad Denmark ApS, Denmark.
Medrad do Brasil Ltda., Brazil.
Medrad Europe B.V., Netherlands.
Medrad France S.A.R.L., France.
Medrad Italia S.r.l., Italy.
Medrad Medical Equipment Trading Co., China.
Medrad Medizinische Systeme GmbH, Germany.
Medrad Mexicana S. de R.L. de CV, Mexico.
Medrad Sweden AB, Sweden.
Medrad UK Ltd., UK.
Medrad, Inc., USA.
MENADIER Heilmittel GmbH, Germany.
Nihon Medrad K.K., Japan.
NippoNex Inc., USA.
NOR-AM Agro LLC, USA.
NOR-AM Land Co., USA.
Nunhems B.V., Netherlands.
Nunhems Beijing Seeds Co. Ltd., China.
Nunhems Chile S.A., Chile.
Nunhems do Brasil Comercio de Sementes Ltds., Brazil.
Nunhems France S.A.R.L., France.
Nunhems Hungary Kft., Hungary.
Nunhems India Private Ltd., India.
Nunhems Italy S.r.l., Italy.
Nunhems Mexico S.A. de C.V., Mexico.
Nunhems Netherlands B.V., Netherlands.
Nunhems Poland Sp. z.o.o., Poland.
Nunhems Spain, S.A., Spain.
Nunhems Tohumculuk Ltd. Sirketi, Turkey.
Nunhems USA, Inc., USA.
Pallas Versicherung AG, Germany.
Paltough Industries (1998) Ltd., Israel.
Pandias Re AG, Luxembourg.
Pathway Medical Technologies, Inc., USA.
PGS International N.V., Netherlands.
Pharma-Verlagsbuchhandlung GmbH, Germany.
PO JV, LP, USA.
Productos Quimicos Naturales, S.A. de C.V., Mexico.
PT. Bayer Indonesia, Indonesia.
PT. Bayer MaterialScience Indonesia, Indonesia.
SB Capital Corporation, USA.
SC Bayer SRL, Romania.
Schering Berlin Inc., USA.
Schering do Brasil Quimica e Farmaceutica Ltda., Brazil.
Schering Holdings Ltd., UK.
Schering International Holding GmbH, Germany.
Schering-Kahlbaum Gesellschaft mit beschränkter Haftung, Germany.
Siebte Bayer VV GmbH, Germany.
Soytech Seeds Pesquisa em Soja Ltda., Brazil.
Stoneville Pedigreed Seed Co., USA.
STWB Inc., USA.
Sumika Bayer Urethane Co. Ltd., Japan.
TECTRION GmbH, Germany.
Texas Brine Co. LLC, USA.
TOO Bayer KAZ, Kazakhstan.
TravelBoard GmbH, Germany.
U I M Agrochemicals (Aust) Pty Ltd., Australia.
UAB Bayer, Lithuania.
Worldwide Soy Technologies, LLC, USA.
ZAO Bayer, Russia.
Zweite K-W-A Beteiligungsgesellschaft mbH, Germany.
etc.
21927744
0636023
Managing
Director: Mr. Johannes Matthias Dietsch
Nominal Share
Capital: HK$100,000.00 (Divided into 100,000 shares of HK$1.00 each)
Issued Share
Capital: HK$100,000.00
(As per registry dated 11-02-2012)
|
Name |
|
No.
of shares |
|
Bayer Far East Service Co. Ltd., Hong
Kong. |
|
100,000 ====== |
(As per registry dated 11-02-2012)
|
Name (Nationality) |
Address |
|
Johannes
Matthias DIETSCH |
Unit 2902, Block 8, Lane 600, Middle Yin
Cheng Road, Pudong, Shanghai 200120, China. |
|
Michael KOENIG |
W30, Tomson Golf Villa, 1 Long Dong Da
Dao, Pudong, Shanghai 201203, China. |
(As per registry dated 11-02-2012)
|
Name |
Address |
|
LEE
Yuk Kwan |
Flat 1115, 11/F., Sheung Yat House, Upper Ngau Tau Kok Estate, Kwun
Tong, Kowloon, Hong Kong. |
The
subject was incorporated on 11th February, 1998 as a private limited liability
company under the Hong Kong Companies Ordinance.
Originally
the subject was registered under the name of King Lion Corporation Ltd., name
changed to Sybron Chemicals (Hong Kong) Ltd. on 31st July, 1998; changed to
Bayer Polymers Co. Ltd. on 26th September, 2001; and further to the present
style on 1st September, 2004.
Formerly
the subject was located at 77/F., The Center, 99 Queen’s Road Central, Hong
Kong, moved to the present address with effect from 18th June, 2012.
Apart
from these, neither material change nor amendment has been ever traced and
noted.
Activities: Importer and Exporter.
Lines: All kinds of plastic raw materials.
Company Employees: 180. (Hong Kong) - Including associates
Group Employees:- (As at 30-06-2012)
112,300. (Whole Group)
14,800. (Bayer MaterialScience Subgroup)
Commodities Imported: Germany, other European countries, India, etc.
Markets: Worldwide.
Group Net Turnover:-
|
FY |
Whole
Group |
Bayer
MaterialScience Subgroup |
|
Year ended 31-12-2007 |
€32,385 million |
€10,435 million |
|
Year ended 31-12-2008 |
€32,918 million |
€ 9,738 million |
|
Year ended 31-12-2009 |
€31,168 million |
€ 7,520 million |
|
Year ended 31-12-2010 |
€35,088 million |
€10,154 million |
|
Year ended 31-12-2011 |
€36,528 million |
€10,832 million |
|
6 months ended 30-06-2012 |
€20,233
million |
€ 5,750 million |
Terms/Sales: L/C
or as per contracted.
Terms/Buying: L/C,
D/P, etc.
The Hong Kong General Chamber of Commerce,
Hong Kong.
[Membership No. HKB0043]
Nominal Share
Capital: HK$100,000.00 (Divided into 100,000 shares of HK$1.00 each)
Issued Share
Capital: HK$100,000.00
Group Net Income: €4,711 million (Year ended 31-12-2007)
€1,719
million (Year ended 31-12-2008)
€1,359
million (Year ended 31-12-2009)
€1,301
million (Year ended 31-12-2010)
€2,470
million (Year ended 31-12-2011)
€1,544
million (6 months ended 30-06-2012)
MaterialScience EBIT: €337 million (6 months ended 30-06-2012)
Profit or Loss: Business is profitable.
Condition: Keeping in an active and satisfactory manner.
Facilities: Making active use of general banking facilities.
Payment: Met trade commitments on time.
Commercial Morality: Good.
Banker: Deutsche Bank AG, Hong Kong Branch.
Standing: Very Good.
Bayer
MaterialScience Ltd. is a wholly-owned subsidiary of Bayer Far East Service Co.
Ltd. [Bayer FE], a Hong Kong-registered firm located at the subject’s operating
address. In turn, Bayer FE is a
subsidiary of Bayer MaterialScience AG [Bayer MaterialScience], Germany. The ultimate holding company of the subject
is Bayer AG [Bayer], a world famous Germany-based firm which is the holding
company of the Bayer Group.
The
subject is trading in the products of the Group.
The
Group is principally engaged in supplying plastics, basic and fine chemicals
flavours, fragrances and aromatic chemicals, polyurethanes, synthetic rubbers
and rubber chemicals, coating and colorants, specialty products, fibres,
pharmaceuticals, diagnostics, consumer care, crop protection and animal-health
products to the Chinese market and importing finished and semi-finished raw
materials and other intermediates and native products from the People’s
Republic of China.
Bayer
is one of the largest diversified international health care and chemicals
groups. Founded in 1863 and
headquartered at Leverkusen, Germany, Bayer today has subsidiaries or agencies
in almost every country in the world.
Bayer
(China) Ltd., a wholly-owned holding company, was registered in Beijing in
September 1994 and is responsible for Bayer’s investments in China.
Bayer
has eleven joint ventures and one wholly-owned enterprise in China: Bayer
Healthcare Co. Ltd., Rhein Chemie (Qingdao) Ltd., Bayer Wuxi Leather Chemical
Co. Ltd., Bayer Shanghai Pigments Co. Ltd., Bayer Sichuan Animal Health Co.
Ltd., H & R Cosfra Ltd., Bayer Guangyi Panel Co. Ltd., Bayer Jinling
Polyurethane Co. Ltd., Bayer Zhongxi Agrochemcial Co. Ltd., Bayer Zhongxi
Consumer Care Co. Ltd., and Shanghai Fortune Long March - Trace Medical Science
Co. Ltd.
Currently,
the subject is trading in the following products and offering clients with the
following services:-
|
Product/Service |
Product/Service
Remarks |
|
Pharmaceutical
and Medicine |
|
|
Veterinary
Medicine |
From
Germany (Importer) From
Germany (Exporter) |
|
Pharmaceutical
Preparation |
Include
veterinary from Germany (Importer) Include
veterinary from Germany (Exporter) |
|
Chemicals
(including Plastic Materials) |
|
|
Plastic
Materials (including Resins and Sheet) |
Include
fluorescent plastic from Western Europe (Importer) Include
fluorescent plastic from Western Europe (Exporter) |
|
Textile
Chemicals |
|
|
Dyeing, Tanning
and Colouring Materials |
Dyestuff
from Germany (Importer) Dyestuff
from Germany (Exporter) |
|
Industrial
Chemicals |
From
Germany (Importer) From
Germany (Exporter) |
|
Household
Chemicals |
|
|
Insecticide |
|
|
Agro-Chemicals |
|
|
Pesticide For
Agricultural Use |
|
The subject
carries the following brands:-
|
Brand
Name |
Brand
Product/Service |
Brand
Remarks |
|
Bayer
(Brand Owner) |
Pharmaceutical
Preparation |
|
|
Veterinary
Medicine |
|
|
|
Agro-Chemicals |
|
|
|
Pesticide
For Agricultural Use |
|
|
|
Insecticide |
Insecticides |
|
|
Industrial
Chemicals |
|
|
|
Dyeing,
Tanning and Colouring Materials |
|
|
|
Plastic
Materials (including Resins and Sheet) |
|
|
|
Haarmann
And Reimer (Official Agent) |
Industrial
Chemicals |
SPICE |
Bayer
MaterialScience is an independent, globally operating company within the Bayer
Group. The name Bayer MaterialScience stands
for the materials that the company develops and produces. It also stands for the know-how and expertise
of its employees all over the world.
Bayer
MaterialScience’s famous products are coating raw materials bearing the
brandnames of “Bayhydrol®” and “Bayhydur®”. High-grade “Makrolon®”, “Makrofol®”
and “Apec®” polycarbonates,
together with the “Bayblend®” and “Makroblend®” polycarbonate blends,
rank among Bayer MaterialScience’s best-sellers. These products are indispensable when it
comes to the production of automotive components, data carriers such as CDs and
DVDs, and a large number of other everyday items. The key product brands of Polyurethanes are “Desmodur®”
and “Desmophen®”. Resins under
the brand names “Desmopan®” and “Texin®” are used in technical
films and textile coatings, belts, hoses, cables and profiles, in the
automotive sector (interior, exterior, and chassis), in a multitude of
applications in sports and leisure (e.g. ski and sport shoes and sport
equipment), etc.
For
the year ended 31st December, 2011, Bayer’s sales rose by 4.0% to a record
€36.5 billion from €35.1 billion in FY 2010.
Net income of the Group was €2.5 billion (2010: €1.3 billion).
With
2011 sales of €10.8 billion, Bayer MaterialScience is among the world’s largest
polymer companies. Business activities
are focused on the manufacture of high-tech polymer materials and the
development of innovative solutions for products used in many areas of daily
life. The main segments served are the
automotive, electrical and electronics, construction and the sports and leisure
industries.
The
main customer industries for MaterialScience also did not entirely escape the
steady weakening of the global economy during the FY 2011. Negative factors included the euro crisis,
the sluggish recovery of domestic demand and the real-estate market in North
America, and the strict measures adopted to tackle inflation and economic
overheating in Asia.
At
the end of 2011, Bayer MaterialScience had 30 production sites and employed
approximately 14,800 people around the globe.
For
the first half year [H1] ended 30th June, 2012, sales of the Group climbed by
5.1% to €20,233 million (reported: +8.4%; H1 2011: €18,667 million).
MaterialScience
raised sales by a currency- and portfolio-adjusted 2.2% (reported: +5.2%).
The
Group anticipates slower growth overall in 2012 in the global markets of
importance to materialScience. The
ongoing Euro crisis in particular is holding back consumption. By contrast, demand will probably continue to
be supported by the economic growth momentum in Asia.
Following
the good business performance in the first half of 2012, especially at
CropScience and Health-Care, the Group is also confident for the second half of
the year. In addition, the Group is
benefiting from a very favorable currency environment. Against this background, the Group is raising
its sales and earnings forecast for the full year. These predictions are based on the exchange
rates on 30th June, 2012.
For
the full year 2012, the Group is now anticipating a currency- and portfolio
adjusted sales increase of between 4% and 5% (previously: 3%). This would result in Group sales of between
approximately €39 billion and €40 billion (previously: €37 billion).
For
MaterialScience, in the third quarter of 2012 the Group aspires to achieve
currency- and portfolio-adjusted sales and EBITDA before special items on the
level of the good second quarter. The
Group continues to plan for currency- and portfolio-adjusted sales and EBITDA
before special items in 2012 to remain level with the prior year.
As
at 30th June, 2012, the Bayer Group employed 112,300 people worldwide (31st
December 2011: 111,800). The number of
employees thus remained practically constant (+0.4%).
The
subject is fully supported by Bayer MaterialScience and ultimately by Bayer.
On
the whole, in view of the parentage of the subject, consider it good for normal
business engagements.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.33 |
|
UK Pound |
1 |
Rs.80.89 |
|
Euro |
1 |
Rs.70.73 |
INFORMATION DETAILS
|
Report Prepared
by : |
PDT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.